influenza test data. 2 The consequent network and data monitoring Data generated from the NYS PHL, the Wadsworth Center, were measured against sample numbers calculated with the computer models for influenza situational awareness and rare/novel event detection.
New York State alternate data from clinical and commercial laboratories were analyzed for integrity and impact on influenza situational awareness. Regional NYS PHL data were assessed for its impact on rare/novel event detection. New York State Department of Health scientific staff in the Virology Laboratory at the Wadsworth Center, in partnership with epidemiologists from the Bureau of Communicable Disease Control (BCDC), evaluated influenza testing practices, regulations, infrastructure, data collection, and reporting. Additionally, surveillance policy, potential future ideal practices and systems, and likely hurdles that may impede implementation were discussed.
| METHODS

| Situational awareness of influenza viral disease in NYS
| Laboratory networks of influenza data sources
The NYS Wadsworth Center PHL performs influenza testing on specimens received through the Influenza-like Illness Network (ILINet) and Emerging Infections Program (EIP), in addition to samples received from non-EIP hospitals, student health clinics, veteran administration (VA) centers, long-term care facilities, correctional facilities, and occasionally commercial laboratories.
The ILINet is an outpatient influenza surveillance program supported by CDC in all states. 
| Reporting of influenza data in NYS
The Electronic Clinical Laboratory Reporting System (ECLRS) provides an electronic system for prompt and protected transmission of reportable disease information to the NYSDOH, local health departments, and the NYCDOHMH. 
| Rare/novel influenza virus detection with NYS PHL data sources
Revised recommendations released in 2014 11 advised using only PHL data generated with molecular methods for the assessment of sample 
| RESULTS
| Recommended sample sizes for NYS influenza surveillance
The goal for NYS is to obtain recommended sample sizes for the state population of approximately 20 million, which would ensure optimal detection thresholds with ≥95% confidence and ≤5% margin of error (MOE), for both situational awareness and rare/novel event detection (Table 2 ). Computer modeling software for situational awareness with
Calculator A establishes ideal sample sizes using unscreened MA-ILI specimens. For detection of a rare/novel event, the current Calculator B revised late 2015 uses only Flu+ specimens tested at state PHLs.
| Sample size calculations for situational awareness in NYS
New York State influenza test data were compared with the recommended sample sizes for situational awareness as determined with Calculator A (Figure 2 ). To avoid bias, specimens should preferably be unscreened, or a random sampling. The Wadsworth Center
Virology Laboratory receives specimens for influenza testing from many sources including some that are prescreened by IVADs or other methods. During most weeks of peak influenza activity, sample sizes needed to achieve ≥95% confidence levels for situational awareness 
| Sample size calculations for rare/novel virus detection with NYS PHL data
For the detection of a rare/novel influenza virus, Wadsworth test data were compared to recommended sample sizes for NYS, aggregated on a national scale, determined from Calculator B ( Figure 5 ).
The total number of Flu+ specimens tested at the Wadsworth Center was insufficient to detect a rare/novel event for influenza surveil- detecting a rare/novel influenza virus, combined sample sizes from Wadsworth and the regional PHLs were sufficient to reach minimum confidence levels (≥85%) for recommended detection thresholds during peak weeks of influenza activity, and optimal (≥95%) confidence for the majority of low season and all of off-season, yet not throughout the year. 
| DISCUSSION
their data shared with CDC by the NYSDOH. These ECLRS/CDESS data consist of only influenza-positive cases, and sufficient numbers are not attained for situational awareness in the off-season months.
The CDESS Flu+ cases for NYS surveillance comprise a large alternate data source that is not currently transmitted to the CDC and provides an indicator of prevailing influenza strains.
In the months preceding peak influenza activity, more samples were tested by IVAD than PCR, yet the reliability of the IVAD data is questionable. Some providers submit IVAD-positive specimens to T A B L E 2 Sample sizes calculated for NYS using the influenza Virologic Surveillance Right Size roadmap calculators A and B for 2013-14
Wadsworth molecular data were insufficient to achieve recom- 
